Literature DB >> 17572156

Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88- and Syk kinase-dependent pathways.

Bing Li1, Daniel Cramer, Stephanie Wagner, Richard Hansen, Chelsea King, Shelly Kakar, Chuanlin Ding, Jun Yan.   

Abstract

The therapeutic benefits of fungal beta-glucans have been demonstrated as immuno-stimulating agents. In this study, we aimed to explore the mechanisms used by yeast beta-glucan-rich particles to activate murine resident macrophages for cytokine secretion. We demonstrated that resident macrophages were effectively activated by whole yeast beta-glucan particles (WGPs), such as with the upregulation of co-stimulatory molecules and the secretion of cytokines. The binding ability of WGPs and the levels of cytokine secretion in resident macrophages were significantly inhibited by soluble yeast beta-glucan but not by blockade of zymosan glucan receptor dectin-1. In addition, WGP-stimulated cytokine secretion was partially dependent on the MyD-88 pathway but was not significantly affected in CR3-deficient (CR3(-/-)) mice. Furthermore, we showed that Syk kinase was recruited upon WGP stimulation and was required for the production of cytokines. Taken together, these observations suggest that beta-glucan recognition is necessary but not sufficient to induce inflammatory response on resident macrophages. In addition, beta-glucan particles may use differential mechanisms for cytokine secretion in resident macrophages that may modulate both innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572156      PMCID: PMC2017100          DOI: 10.1016/j.clim.2007.05.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  40 in total

1.  Immune recognition. A new receptor for beta-glucans.

Authors:  G D Brown; S Gordon
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

Review 2.  Src and Syk kinases: key regulators of phagocytic cell activation.

Authors:  Giorgio Berton; Attila Mócsai; Clifford A Lowell
Journal:  Trends Immunol       Date:  2005-04       Impact factor: 16.687

3.  Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.

Authors:  Nai-Kong V Cheung; Shakeel Modak
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

4.  Human monocyte scavenger receptors are pattern recognition receptors for (1-->3)-beta-D-glucans.

Authors:  Peter J Rice; Jim L Kelley; Grigorij Kogan; Harry E Ensley; John H Kalbfleisch; I William Browder; David L Williams
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

5.  Glucan stimulates human dermal fibroblast collagen biosynthesis through a nuclear factor-1 dependent mechanism.

Authors:  Duo Wei; Leiying Zhang; David L Williams; I William Browder
Journal:  Wound Repair Regen       Date:  2002 May-Jun       Impact factor: 3.617

6.  Anthrax-protective effects of yeast beta 1,3 glucans.

Authors:  Bill Kournikakis; Rosemonde Mandeville; Pauline Brousseau; Gary Ostroff
Journal:  MedGenMed       Date:  2003-03-21

7.  Dectin-1 mediates the biological effects of beta-glucans.

Authors:  Gordon D Brown; Jurgen Herre; David L Williams; Janet A Willment; Andrew S J Marshall; Siamon Gordon
Journal:  J Exp Med       Date:  2003-04-28       Impact factor: 14.307

8.  Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.

Authors:  Benjamin N Gantner; Randi M Simmons; Scott J Canavera; Shizuo Akira; David M Underhill
Journal:  J Exp Med       Date:  2003-04-28       Impact factor: 14.307

Review 9.  Tyrosine kinase SYK: essential functions for immunoreceptor signalling.

Authors:  M Turner; E Schweighoffer; F Colucci; J P Di Santo; V L Tybulewicz
Journal:  Immunol Today       Date:  2000-03

10.  Dectin-1 is a major beta-glucan receptor on macrophages.

Authors:  Gordon D Brown; Philip R Taylor; Delyth M Reid; Janet A Willment; David L Williams; Luisa Martinez-Pomares; Simon Y C Wong; Siamon Gordon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  18 in total

1.  Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer.

Authors:  Mei Zhang; Liane Chun; Victor Sandoval; Hallie Graor; Jay Myers; Joseph Nthale; Peter Rauhe; Zachary Senders; Kevin Choong; Alex Y Huang; Julian Kim
Journal:  Oncoimmunology       Date:  2017-10-30       Impact factor: 8.110

2.  β-Glucans inhibit intracellular growth of Mycobacterium bovis BCG but not virulent Mycobacterium tuberculosis in human macrophages.

Authors:  Bret E Betz; Abul K Azad; Jessica D Morris; Murugesan V S Rajaram; Larry S Schlesinger
Journal:  Microb Pathog       Date:  2011-07-05       Impact factor: 3.738

3.  Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Authors:  Hongmei Li; Patricia Gonnella; Farinaz Safavi; Ghazal Vessal; Bardia Nourbakhsh; Fang Zhou; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-09-23       Impact factor: 3.478

4.  Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.

Authors:  Bing Li; Yihua Cai; Chunjian Qi; Richard Hansen; Chuanlin Ding; Thomas C Mitchell; Jun Yan
Journal:  Clin Cancer Res       Date:  2010-09-20       Impact factor: 12.531

5.  Improved antimicrobial host defense in mice following poly-(1,6)-β-D-glucopyranosyl-(1,3)-β-D-glucopyranose glucan treatment by a gender-dependent immune mechanism.

Authors:  Courtni T Newsome; Estefany Flores; Alfred Ayala; Stephen Gregory; Jonathan S Reichner
Journal:  Clin Vaccine Immunol       Date:  2011-10-05

6.  Immunomodulatory beta-glucan from Lentinus edodes activates mitogen-activated protein kinases and nuclear factor-kappaB in murine RAW 264.7 macrophages.

Authors:  Xiaojuan Xu; Chen Pan; Lina Zhang; Hitoshi Ashida
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

7.  Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Claudia Salazar-Aldrete; Marta Galán-Díez; Elena Fernández-Ruiz; Perla Niño-Moreno; Lizbeth Estrada-Capetillo; Carlos Abud-Mendoza; Esther Layseca-Espinosa; Lourdes Baranda; Roberto González-Amaro
Journal:  J Clin Immunol       Date:  2012-10-25       Impact factor: 8.317

8.  Aureobasidium-derived soluble branched (1,3-1,6) beta-glucan (Sophy beta-glucan) enhances natural killer activity in Leishmania amazonensis-infected mice.

Authors:  Lalani Yatawara; Susiji Wickramasinghe; Mitsuru Nagataki; Misa Takamoto; Haruka Nomura; Yasunori Ikeue; Yoshiya Watanabe; Takeshi Agatsuma
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

Review 9.  Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.

Authors:  Jingjing Liu; Lacey Gunn; Richard Hansen; Jun Yan
Journal:  Exp Mol Pathol       Date:  2009-01-21       Impact factor: 3.362

10.  Candida Administration in Bilateral Nephrectomy Mice Elevates Serum (1→3)-β-D-glucan That Enhances Systemic Inflammation Through Energy Augmentation in Macrophages.

Authors:  Jiraphorn Issara-Amphorn; Cong Phi Dang; Wilasinee Saisorn; Kavee Limbutara; Asada Leelahavanichkul
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.